Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study

Fabio Timeus, Nicoletta Crescenzio, Daniela Longoni, Alessandra Doria, Luiselda Foglia, Sara Pagliano, Stefano Vallero, Valentina Decimi, Johanna Svahn, Giuseppe Palumbo, Antonio Ruggiero, Baldassarre Martire, Marta Pillon, Nicoletta Marra, Carlo Dufour, Ugo Ramenghi, Paola Saracco

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.

Original languageEnglish
Article numbere101948
JournalPLoS One
Volume9
Issue number7
DOIs
Publication statusPublished - Jul 9 2014

Fingerprint

hemoglobinuria
Paroxysmal Hemoglobinuria
Aplastic Anemia
Phosphatidylinositols
anemia
Multicenter Studies
Clone Cells
clones
Population
therapeutics
hemolysis
Hemolysis
inositols
Therapeutics
Hemoglobinuria
Immunologic Monitoring
cyclosporine
Monitoring
monitoring
Delayed Diagnosis

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Timeus, F., Crescenzio, N., Longoni, D., Doria, A., Foglia, L., Pagliano, S., ... Saracco, P. (2014). Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study. PLoS One, 9(7), [e101948]. https://doi.org/10.1371/journal.pone.0101948

Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia : A multicentre study. / Timeus, Fabio; Crescenzio, Nicoletta; Longoni, Daniela; Doria, Alessandra; Foglia, Luiselda; Pagliano, Sara; Vallero, Stefano; Decimi, Valentina; Svahn, Johanna; Palumbo, Giuseppe; Ruggiero, Antonio; Martire, Baldassarre; Pillon, Marta; Marra, Nicoletta; Dufour, Carlo; Ramenghi, Ugo; Saracco, Paola.

In: PLoS One, Vol. 9, No. 7, e101948, 09.07.2014.

Research output: Contribution to journalArticle

Timeus, F, Crescenzio, N, Longoni, D, Doria, A, Foglia, L, Pagliano, S, Vallero, S, Decimi, V, Svahn, J, Palumbo, G, Ruggiero, A, Martire, B, Pillon, M, Marra, N, Dufour, C, Ramenghi, U & Saracco, P 2014, 'Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study', PLoS One, vol. 9, no. 7, e101948. https://doi.org/10.1371/journal.pone.0101948
Timeus, Fabio ; Crescenzio, Nicoletta ; Longoni, Daniela ; Doria, Alessandra ; Foglia, Luiselda ; Pagliano, Sara ; Vallero, Stefano ; Decimi, Valentina ; Svahn, Johanna ; Palumbo, Giuseppe ; Ruggiero, Antonio ; Martire, Baldassarre ; Pillon, Marta ; Marra, Nicoletta ; Dufour, Carlo ; Ramenghi, Ugo ; Saracco, Paola. / Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia : A multicentre study. In: PLoS One. 2014 ; Vol. 9, No. 7.
@article{7039115a3e3443119b32d6b414c92aca,
title = "Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study",
abstract = "A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41{\%} of patients at diagnosis, 48{\%} during immune-suppressive therapy (IST), and 45{\%} in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10{\%}, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10{\%}, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.",
author = "Fabio Timeus and Nicoletta Crescenzio and Daniela Longoni and Alessandra Doria and Luiselda Foglia and Sara Pagliano and Stefano Vallero and Valentina Decimi and Johanna Svahn and Giuseppe Palumbo and Antonio Ruggiero and Baldassarre Martire and Marta Pillon and Nicoletta Marra and Carlo Dufour and Ugo Ramenghi and Paola Saracco",
year = "2014",
month = "7",
day = "9",
doi = "10.1371/journal.pone.0101948",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia

T2 - A multicentre study

AU - Timeus, Fabio

AU - Crescenzio, Nicoletta

AU - Longoni, Daniela

AU - Doria, Alessandra

AU - Foglia, Luiselda

AU - Pagliano, Sara

AU - Vallero, Stefano

AU - Decimi, Valentina

AU - Svahn, Johanna

AU - Palumbo, Giuseppe

AU - Ruggiero, Antonio

AU - Martire, Baldassarre

AU - Pillon, Marta

AU - Marra, Nicoletta

AU - Dufour, Carlo

AU - Ramenghi, Ugo

AU - Saracco, Paola

PY - 2014/7/9

Y1 - 2014/7/9

N2 - A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.

AB - A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.

UR - http://www.scopus.com/inward/record.url?scp=84904055814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904055814&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0101948

DO - 10.1371/journal.pone.0101948

M3 - Article

C2 - 25007335

AN - SCOPUS:84904055814

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e101948

ER -